| Full Name | Diem Huyen Vo |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 9521 Dalen St, Downey, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851922520 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 50361 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diem Huyen Vo, 9521 Dalen St, Downey, CA 90242-4847 Ph: () - | Diem Huyen Vo, 9521 Dalen St, Downey, CA 90242-4847 Ph: (562) 401-4200 |
News Archive
Kaiser Health News' Jessica Marcy talked with Dr. Abraham Verghese about a range of issues related to health reform and the practice of medicine. Verghese, a senior associate chair at Stanford University's School of Medicine and a best-selling author, spoke about "how medical educators are addressing the shortage of primary care physicians and the 'battle of stories' in the health care reform debate" (Marcy, 9/15).
Bladder cancer will kill upward of 170,000 people worldwide this year, but bladder cancer isn't fatal in the bladder. Instead, in order to be fatal the disease must metastasize to faraway sites. The question has been this: does localized, non-muscle invasive bladder cancer eventually become the more dangerous, muscle-invasive form of the disease, or are NMI and MI bladder cancers genetically distinct from the start?
Recently published research shows that learning disabilities diagnosed in childhood are associated with adult-age mental health problems, delays or difficulties in attaining an educational degree, and unemployment.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
› Verified 2 days ago
Lindy Garrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9161 Via Amorita, Downey, CA 90241 Phone: 562-879-3616 | |
Erwin W.s. Jeong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12254 Bellflower Blvd, Drug Info - 1st Floor, Downey, CA 90242 Phone: 562-658-3751 | |
Nikki Du, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9449 Imperial Hwy, Downey, CA 90242 Phone: 562-657-2334 | |
Michael Luhm, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9333 Imperial Hwy, 1st Floor Outpatient Pharmacy, Downey, CA 90242 Phone: 562-657-9421 | |
Dr. Joon Cha, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9449 Imperial Hwy, Downey, CA 90242 Phone: 562-657-2026 | |
Danny D Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9521 Dalen St, Downey, CA 90242 Phone: 866-206-2983 | |
Dr. Abraham Koun-kuk Kim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12254 Bellflower Blvd Fl 2, Downey, CA 90242 Phone: 562-774-5029 |